Lantheus Holdings Inc (LNTH) — Technical state
As of 2026-11-02 — re-computed nightly across the coverage universe. Closelooknet diary readings, not advice.
The Closelooknet read
- Closelooknet score: 60 out of 100 (momentum 72 · quality 73 · valuation 55), as of 2026-11-03.
- Signal: Uptrend stack intact — Trades +0% vs the 50-day and +9.6% vs the 200-day average, 10.3% below the 52-week high and +100% off the 52-week low. Computed from daily closes. (as of 2026-11-02)
- Trend: Lantheus Holdings Inc trades 0.0% above its 50-day and 9.6% above its 200-day moving average. (as of 2026-11-02)
Lantheus develops diagnostic and therapeutic products used in imaging and treating heart disease, cancer and other conditions. Its portfolio includes DEFINITY for echocardiography, TechneLite and Xenon-133 for nuclear medicine, and PYLARIFY, a PET imaging agent used to detect prostate cancer.
The full read — the desk's view, the earnings record, peers and the company snapshot — is on the LNTH overview. Agents can buy the score depth per call over HTTP 402 — see the catalogue. Research diary readings, not advice.
Trades +0% vs the 50-day and +9.6% vs the 200-day average, 10.3% below the 52-week high and +100% off the 52-week low. Computed from daily closes.
The moving-average stack
- vs 20-day+0.2%
- vs 50-day+0%
- vs 200-day+9.6%
- 52-week band10.3% off the high · +100% off the low
- Streak1 consecutive down session
- 50-day crossprice crossed up through the 50-day 2 sessions ago
- Stochastic%K 71.9 · %D 78.1 · bear cross
Continue: the LNTH chart & overview · quality & forensics · the earnings record · the signal board
FAQ · from the current data · as of 2026-11-02
Quick answers
What is the current Closelooknet signal on LNTH?
Uptrend stack intact — Trades +0% vs the 50-day and +9.6% vs the 200-day average, 10.3% below the 52-week high and +100% off the 52-week low. Computed from daily closes. As of 2026-11-02; the signal board re-computes across the coverage universe nightly. A research diary reading, not advice.
Is LNTH above its 50-day and 200-day moving averages?
As of 2026-11-02, Lantheus Holdings Inc trades +0% above its 50-day and +9.6% above its 200-day average, with the 20-day +0.2% away.
How far is LNTH from its 52-week high?
10.3% below the 52-week high and 100% above the 52-week low, as of 2026-11-02.
Related in the Closelooknet universe
then Drug Manufacturers - Specialty & Generic. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.
- ROVI.MC Laboratorios Farmaceuticos ROVIindustry
- GALDY GALDERMA GROUP AGindustry
- KNSA Kiniksa Pharmaceuticals Ltdindustry
- ALM.MC Almirall S.A.industry
- IRWD Ironwood Pharmaceuticals Incindustry
- FAGR.BR Fagron NVindustry
- BHC.TO Bausch Health Companies Incindustry
- PCRX Pacira BioSciences, Inc.industry
- HLUN-B.CO H Lundbeck A/Sindustry
- UTHR United Therapeutics Corporationindustry
- VETO.PA Vetoquinolindustry
- XERS Xeris Pharmaceuticals Incindustry
- AMPH Amphastar Pindustry
- GUD.TO Knight Therapeutics Inc.industry
- VTRS Viatris Incindustry
- 000538.SHE Yunnan Baiyao Group Co Ltdindustry
- PRGO Perrigo Company PLCindustry
- ELAN Elanco Animal Healthindustry
- FAE.MC Faes Farma SAindustry
- INDV Indivior PLC Ordinary Sharesindustry